Top Biotechnology & Medical Research stocks in North America

Researchers and developers of biotechnology based drugs and therapies as well as medical devices and procedures that are at an early (non-commercial) stage.

Name	Market Cap	Price to Earnings TTM	Dividend Yield % TTM
DNTHDianthus Therapeutics	$1.81bn	n/a	n/a
IMNMImmunome	$1.79bn	n/a	n/a
INBXInhibrx	$1.79bn	n/a	n/a
SNDXSyndax Pharmaceuticals	$1.77bn	n/a	n/a
AMAMAmbrx Biopharma	$1.76bn	n/a	n/a
ALVOAlvotech SA	$1.74bn	36.56	n/a
TRVITrevi Therapeutics	$1.64bn	n/a	n/a
AZTAAzenta	$1.62bn	54.96	n/a
BCRXBioCryst Pharmaceuticals	$1.59bn	n/a	n/a
AGIOAgios Pharmaceuticals	$1.59bn	n/a	n/a
TSHATaysha Gene Therapies	$1.59bn	n/a	n/a
PHVSPharvaris NV	$1.57bn	n/a	n/a
ATAIAtai Beckley NV	$1.56bn	n/a	n/a
BHVNBiohaven	$1.53bn	n/a	n/a
ARDXArdelyx	$1.51bn	n/a	n/a
UPBUpstream Bio	$1.47bn	n/a	n/a
ORKAOruka Therapeutics	$1.46bn	n/a	n/a
FTREFortrea Holdings	$1.45bn	n/a	n/a
RAPPRapport Therapeutics	$1.44bn	n/a	n/a
AMLXAmylyx Pharmaceuticals	$1.44bn	n/a	n/a